These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8195051)

  • 1. New polyenic antibiotics active against gram-positive and gram-negative bacteria. IX. Reclassification of a strain W-315 producing enacyloxins.
    Watanabe T; Sugiyama T; Izaki K
    J Antibiot (Tokyo); 1994 Apr; 47(4):496-8. PubMed ID: 8195051
    [No Abstract]   [Full Text] [Related]  

  • 2. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VIII. Construction of synthetic medium for production of mono-chloro-congeners of enacyloxins.
    Watanabe T; Sugiyama T; Chino K; Suzuki T; Wakabayashi S; Hayashi H; Itami R; Shima J; Izaki K
    J Antibiot (Tokyo); 1992 Apr; 45(4):476-84. PubMed ID: 1534321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New polyenic antibiotics active against gram-positive and gram-negative bacteria. IV. Structural elucidation of enacyloxin IIa.
    Watanabe T; Sugiyama T; Takahashi M; Shima J; Yamashita K; Izaki K; Furihata K; Seto H
    J Antibiot (Tokyo); 1992 Apr; 45(4):470-5. PubMed ID: 1592680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New polyenic antibiotics active against gram-positive and gram-negative bacteria. V. Mode of action of enacyloxin IIa.
    Watanabe T; Suzuki T; Izaki K
    J Antibiot (Tokyo); 1991 Dec; 44(12):1457-9. PubMed ID: 1778796
    [No Abstract]   [Full Text] [Related]  

  • 5. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VII. Isolation and structure of enacyloxin IVa, a possible biosynthetic intermediate of enacyloxin IIa.
    Watanabe T; Shima J; Izaki K; Sugiyama T
    J Antibiot (Tokyo); 1992 Apr; 45(4):575-6. PubMed ID: 1592689
    [No Abstract]   [Full Text] [Related]  

  • 6. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VI. Non-lactonic polyene antibiotic, enacyloxin IIa, inhibits binding of aminoacyl-tRNA to A site of ribosomes.
    Watanabe T; Okubo N; Suzuki T; Izaki K
    J Antibiot (Tokyo); 1992 Apr; 45(4):572-4. PubMed ID: 1375592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic formation by gram-negative nonsporulating bacteria].
    Ivanitskaia LP; Bodunkova LE; Oparina ON
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):574-84. PubMed ID: 3532937
    [No Abstract]   [Full Text] [Related]  

  • 8. Korormicin, a novel antibiotic specifically active against marine gram-negative bacteria, produced by a marine bacterium.
    Yoshikawa K; Takadera T; Adachi K; Nishijima M; Sano H
    J Antibiot (Tokyo); 1997 Nov; 50(11):949-53. PubMed ID: 9592569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
    Altendorfer M; Irschik H; Menche D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5731-4. PubMed ID: 22832317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of polyketides.
    Rawlings BJ
    Nat Prod Rep; 1997 Oct; 14(5):523-56. PubMed ID: 9364779
    [No Abstract]   [Full Text] [Related]  

  • 11. The Polyene Natural Product Thailandamide A Inhibits Fatty Acid Biosynthesis in Gram-Positive and Gram-Negative Bacteria.
    Wu Y; Seyedsayamdost MR
    Biochemistry; 2018 Jul; 57(29):4247-4251. PubMed ID: 29975047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extracellular quinoprotein oxidase that catalyzes conversion of enacyloxin IVa to enacyloxin IIa.
    Oyama R; Watanabe T; Hanzawa H; Sano T; Sugiyama T; Izaki K
    Biosci Biotechnol Biochem; 1994 Oct; 58(10):1914-7. PubMed ID: 7765518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial growth on dichlorobiphenyls chlorinated on both rings as a sole carbon and energy source.
    Kim S; Picardal F
    Appl Environ Microbiol; 2001 Apr; 67(4):1953-5. PubMed ID: 11282655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Properties of the obligate methylotroph Methylophilus methanolovorus].
    Loginova NV; Trotsenko IuA
    Mikrobiologiia; 1981; 50(1):21-8. PubMed ID: 7219216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New polyenic antibiotics active against gram-positive and -negative bacteria. II. Screening of antibiotic producers and taxonomical properties of Gluconobacter sp. W-315.
    Watanabe T; Izaki K; Takahashi H
    J Antibiot (Tokyo); 1982 Sep; 35(9):1148-55. PubMed ID: 6216234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micromorphology of Gram-negative hydrogen bacteria. I. Cell morphology and flagellation.
    Aragno M; Walther-Mauruschat A; Mayer F; Schlegel HG
    Arch Microbiol; 1977 Aug; 114(2):93-100. PubMed ID: 410385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and identification of broad spectrum antibiotic producing Streptomyces hygroscopicus D 1.5.
    Chakraborty D; Mondal B; Pal SC; Sen SK
    Hindustan Antibiot Bull; 1995; 37(1-4):37-43. PubMed ID: 8972139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.